141 related articles for article (PubMed ID: 35398488)
1. SYK and ZAP70 kinases in autoimmunity and lymphoid malignancies.
Leveille E; Chan LN; Mirza AS; Kume K; Müschen M
Cell Signal; 2022 Jun; 94():110331. PubMed ID: 35398488
[TBL] [Abstract][Full Text] [Related]
2. Developmental partitioning of SYK and ZAP70 prevents autoimmunity and cancer.
Sadras T; Martin M; Kume K; Robinson ME; Saravanakumar S; Lenz G; Chen Z; Song JY; Siddiqi T; Oksa L; Knapp AM; Cutler J; Cosgun KN; Klemm L; Ecker V; Winchester J; Ghergus D; Soulas-Sprauel P; Kiefer F; Heisterkamp N; Pandey A; Ngo V; Wang L; Jumaa H; Buchner M; Ruland J; Chan WC; Meffre E; Martin T; Müschen M
Mol Cell; 2021 May; 81(10):2094-2111.e9. PubMed ID: 33878293
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the mRNA expression profile of B-cell receptor components in normal CD5-high B-lymphocytes and chronic lymphocytic leukemia: a key role of ZAP70.
Gladkikh AA; Potashnikova DM; Tatarskiy V; Yastrebova M; Khamidullina A; Barteneva N; Vorobjev I
Cancer Med; 2017 Dec; 6(12):2984-2997. PubMed ID: 29125235
[TBL] [Abstract][Full Text] [Related]
4. NKG2D triggers cytotoxicity in murine epidermal γδ T cells via PI3K-dependent, Syk/ZAP70-independent signaling pathway.
Ibusuki A; Kawai K; Yoshida S; Uchida Y; Nitahara-Takeuchi A; Kuroki K; Kajikawa M; Ose T; Maenaka K; Kasahara M; Kanekura T
J Invest Dermatol; 2014 Feb; 134(2):396-404. PubMed ID: 23962808
[TBL] [Abstract][Full Text] [Related]
5. ZAP-70 enhances B-cell-receptor signaling despite absent or inefficient tyrosine kinase activation in chronic lymphocytic leukemia and lymphoma B cells.
Gobessi S; Laurenti L; Longo PG; Sica S; Leone G; Efremov DG
Blood; 2007 Mar; 109(5):2032-9. PubMed ID: 17038529
[TBL] [Abstract][Full Text] [Related]
6. CD45 is essential for Fc epsilon RI signaling by ZAP70, but not Syk, in Syk-negative mast cells.
Zhang J; Siraganian RP
J Immunol; 1999 Sep; 163(5):2508-16. PubMed ID: 10452987
[TBL] [Abstract][Full Text] [Related]
7. Redundant role for Zap70 in B cell development and activation.
Fallah-Arani F; Schweighoffer E; Vanes L; Tybulewicz VL
Eur J Immunol; 2008 Jun; 38(6):1721-33. PubMed ID: 18465772
[TBL] [Abstract][Full Text] [Related]
8. Role of spleen tyrosine kinase in the pathogenesis of chronic lymphocytic leukemia.
Feng G; Wang X
Leuk Lymphoma; 2014 Dec; 55(12):2699-705. PubMed ID: 24547708
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of BCR signaling using the Syk inhibitor TAK-659 prevents stroma-mediated signaling in chronic lymphocytic leukemia cells.
Purroy N; Carabia J; Abrisqueta P; Egia L; Aguiló M; Carpio C; Palacio C; Crespo M; Bosch F
Oncotarget; 2017 Jan; 8(1):742-756. PubMed ID: 27888629
[TBL] [Abstract][Full Text] [Related]
10. BCR-associated factors driving chronic lymphocytic leukemia cells proliferation ex vivo.
Schleiss C; Ilias W; Tahar O; Güler Y; Miguet L; Mayeur-Rousse C; Mauvieux L; Fornecker LM; Toussaint E; Herbrecht R; Bertrand F; Maumy-Bertrand M; Martin T; Fournel S; Georgel P; Bahram S; Vallat L
Sci Rep; 2019 Jan; 9(1):701. PubMed ID: 30679590
[TBL] [Abstract][Full Text] [Related]
11. Normal B cells express ZAP70 in chronic lymphocytic leukemia: A link between autoimmunity and lymphoproliferation?
Ghergus D; Martin M; Knapp AM; Delmotte F; Joublin-Delavat A; Jung S; Schickel JN; Mendel I; Dupuis A; Drénou B; Ghesquières H; Salles G; Baseggio L; Herbrecht R; Korganow AS; Vallat L; Soulas-Sprauel P; Meffre E; Martin T
Am J Hematol; 2024 Jan; 99(1):48-56. PubMed ID: 37853951
[TBL] [Abstract][Full Text] [Related]
12. Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia.
Chen L; Widhopf G; Huynh L; Rassenti L; Rai KR; Weiss A; Kipps TJ
Blood; 2002 Dec; 100(13):4609-14. PubMed ID: 12393534
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of constitutive and BCR-induced Syk activation downregulates Mcl-1 and induces apoptosis in chronic lymphocytic leukemia B cells.
Gobessi S; Laurenti L; Longo PG; Carsetti L; Berno V; Sica S; Leone G; Efremov DG
Leukemia; 2009 Apr; 23(4):686-97. PubMed ID: 19092849
[TBL] [Abstract][Full Text] [Related]
14. Integration of innate into adaptive immune responses in ZAP-70-positive chronic lymphocytic leukemia.
Wagner M; Oelsner M; Moore A; Götte F; Kuhn PH; Haferlach T; Fiegl M; Bogner C; Baxter EJ; Peschel C; Follows GA; Ringshausen I
Blood; 2016 Jan; 127(4):436-48. PubMed ID: 26508782
[TBL] [Abstract][Full Text] [Related]
15. BCR signaling in chronic lymphocytic leukemia and related inhibitors currently in clinical studies.
Robak T; Robak P
Int Rev Immunol; 2013 Aug; 32(4):358-76. PubMed ID: 23617253
[TBL] [Abstract][Full Text] [Related]
16. Selective, novel spleen tyrosine kinase (Syk) inhibitors suppress chronic lymphocytic leukemia B-cell activation and migration.
Hoellenriegel J; Coffey GP; Sinha U; Pandey A; Sivina M; Ferrajoli A; Ravandi F; Wierda WG; O'Brien S; Keating MJ; Burger JA
Leukemia; 2012 Jul; 26(7):1576-83. PubMed ID: 22362000
[TBL] [Abstract][Full Text] [Related]
17. The degree of BCR and NFAT activation predicts clinical outcomes in chronic lymphocytic leukemia.
Le Roy C; Deglesne PA; Chevallier N; Beitar T; Eclache V; Quettier M; Boubaya M; Letestu R; Lévy V; Ajchenbaum-Cymbalista F; Varin-Blank N
Blood; 2012 Jul; 120(2):356-65. PubMed ID: 22613791
[TBL] [Abstract][Full Text] [Related]
18. Signaling via LAT (linker for T-cell activation) and Syk/ZAP70 is required for ERK activation and NFAT transcriptional activation following CD2 stimulation.
Martelli MP; Lin H; Zhang W; Samelson LE; Bierer BE
Blood; 2000 Sep; 96(6):2181-90. PubMed ID: 10979964
[TBL] [Abstract][Full Text] [Related]
19. Spleen tyrosine kinase inhibition prevents chemokine- and integrin-mediated stromal protective effects in chronic lymphocytic leukemia.
Buchner M; Baer C; Prinz G; Dierks C; Burger M; Zenz T; Stilgenbauer S; Jumaa H; Veelken H; Zirlik K
Blood; 2010 Jun; 115(22):4497-506. PubMed ID: 20335218
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms determining a differential threshold for sensing Src family kinase activity by B and T cell antigen receptors.
Borna S; Fabisik M; Ilievova K; Dvoracek T; Brdicka T
J Biol Chem; 2020 Sep; 295(37):12935-12945. PubMed ID: 32665402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]